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Age-related DNA methylation changes 
are tissue-specific with ELOVL2 promoter 
methylation as exception
Roderick C. Slieker1* , Caroline L. Relton2, Tom R. Gaunt2, P. Eline Slagboom1 and Bastiaan T. Heijmans1
Abstract 
Background: The well-established association of chronological age with changes in DNA methylation is primarily 
founded on the analysis of large sets of blood samples, while conclusions regarding tissue-specificity are typically 
based on small number of samples, tissues and CpGs. Here, we systematically investigate the tissue-specific character 
of age-related DNA methylation changes at the level of the CpG, functional genomic region and nearest gene in a 
large dataset.
Results: We assembled a compendium of public data, encompassing genome-wide DNA methylation data (Illumina 
450k array) on 8092 samples from 16 different tissues, including 7 tissues with moderate to high sample numbers 
(Dataset size range 96–1202, Ntotal = 2858). In the 7 tissues (brain, buccal, liver, kidney, subcutaneous fat, mono-
cytes and T-helper cells), we identified 7850 differentially methylated positions that gained (gain-aDMPs; cut-offs: 
Pbonf ≤ 0.05, effect size ≥ 2%/10 years) and 4,287 that lost DNA methylation with age (loss-aDMPs), 92% of which had 
not previously been reported for whole blood. The majority of all aDMPs identified occurred in one tissue only (gain-
aDMPs: 85.2%; loss-aDMPs: 97.4%), an effect independent of statistical power. This striking tissue-specificity extended 
to both the functional genomic regions (defined by chromatin state segmentation) and the nearest gene. However, 
aDMPs did accumulate in regions with the same functional annotation across tissues, namely polycomb-repressed 
CpG islands for gain-aDMPs and regions marked by active histone modifications for loss-aDMPs.
Conclusion: Our analysis shows that age-related DNA methylation changes are highly tissue-specific. These results 
may guide the development of improved tissue-specific markers of chronological and, perhaps, biological age.
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Background
The association between DNA methylation and age in 
humans is well established for whole blood [1–10], and 
also in adipose tissue, brain and mesenchymal stem cells, 
loci have been found where DNA methylation changes 
with age [11–13]. A prime example is the CpGs near the 
ELOVL2 gene that exhibit consistent age-related changes 
in blood, hMSCs [13] and teeth [14] and other tissues 
[15, 16], an association that even extends to tissue from 
another species, namely the mouse [17]. The strength of 
the associations has led to the development of multiple 
predictors that can accurately estimate chronological 
age from methylation levels at a limited set of CpG sites 
[18–20]. While most predictors are trained on whole-
blood DNA methylation data, one age predictor works 
independent of tissue type [18–20]. Intuitively, the high 
precision of the tissue-independent age predictor may 
rely on combining the cumulative information of CpGs 
whose DNA methylation level changes with age in mul-
tiple tissues simultaneously [14]. However, current views 
of the extent of tissue-specificity versus tissue-shared 
age-related DNA methylation are based on relatively 
small-scale studies with repect to the number of samples, 
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tissues and/or CpG sites (Table  1). The three previous 
human studies on tissue-specificity  included between 4 
and 92 samples per tissue (and 656 whole-blood samples) 
interrogating 1413, 26,486 and 429,789 CpG sites [13, 21, 
22]. Although two of these studies concluded that age-
related DNA methylation are tissue-specific [13, 21], the 
third reported that age-related changes were both shared 
across tissues and tissue-specific [22]. However, small 
numbers of tissues, samples and CpGs are biased towards 
finding tissue-specificity. Hence, conclusive evidence 
whether age-related changes are tissue-specific or tissue-
shared is lacking. 
Here, we report on a systematic genome-wide analysis 
of age-related DNA methylation changes in a collection 
of 2858 methylomes from 7 tissues and show that the 
DNA methylation changes are highly tissue-specific and 
cannot be attributed to differences in statistical power. 
This tissue-specificity is not restricted to the individual 
CpG site but extends to the level of the functional region 
and the nearest gene to which a CpG maps. However, in 
every tissue, it is the same functional region (non-CGI, 
CGI, polycomb binding site, etc.) that accumulates age-
related changes albeit at distinct locations in the genome.
Results
To investigate age-related DNA methylation changes 
between tissues, Illumina 450k DNA methylation data 
were obtained from public repositories for 16 tissues 
encompassing in total 8092 individuals (Additional file 1: 
Table S1). First, we revisited the age-related differentially 
methylated position (aDMP) near ELOVL2 (cg16867657), 
to test whether the tissue-independent character of this 
aDMP extended to multiple tissues. Gain of methylation 
was observed in blood (N = 3295, Fig. 1a) and extended 
to all tissues investigated except cerebellum (Fig.  1b) in 
line with previous reports [15].
To systematically study the occurrence of tissue-spe-
cific and tissue-shared aDMPs, we identified aDMPs in 
tissues for which a moderate to large sample size was 
available (96 ≤ N≤1202; Additional file  1: Table  S1), 
which included brain (N = 380), buccal (N = 96), liver 
(N = 147), kidney (N = 171), subcutaneous fat (SAT, 
N = 648), monocytes (N = 1202) and T-helper cells (Th 
cells, N = 214). As a comparison, whole-blood aDMPs 
were obtained from our previous work (N = 3295, [23]). 
We focused on a conservative set of aDMPs defined by 
genome-wide significance (Pbonf ≤ 0.05) and a robust age-
related gain or loss that was larger than 2% per 10 years. 
Out of the 428,279 CpGs investigated, 7850 unique CpGs 
gained DNA methylation in one or more tissues (gain-
aDMPs) and 4287 unique CpGs lost DNA methylation 
in one or more tissues (loss-aDMPs). The number of 
aDMPs identified in each tissue varied strongly, with 
the highest number in buccal (4857 aDMPs in N = 96; 
Fig. 2a, Additional File 2: Table S2) and the lowest num-
ber in Th cells (39 aDMPs in N = 214, Additional File 2: 
Table  S2). As expected, whole-blood showed a substan-
tial overlap with monocytes (62 gain-aDMPs, 84 loss-
aDMPs,  Additional File 2: Table  S2) and Th cells (20 
gain-aDMPs, 3 loss-aDMPs, Additional File 2: Table S2). 
Therefore, whole blood was not included in subsequent 
comparative analyses. The number of gain- versus loss-
DMPs differed between tissues. For example, in liver, 
aDMPs mainly gained DNA methylation (gain 2499, loss 
Table 1 Overview of studies of age-related DNA methylation changes in multiple tissues






Human Buccal (96), liver (147), kidney (171)
Th cells (214), brain (603), SC fat (648), monocytes (1202)
428,279
(Illumina 450 k)
+ + + Current study
Human Cervix (3), bladder (5), intestine (5), kidney (6), head/neck 




– – – [21]
Human Muscle (51), blood (71), brain (78), kidney (83) 26,486
(27 k array)
+ – – (GO terms) [22]
Human Neuron (29), glia (29), MSCs (92), whole blood (656) 429,789
(Illumina 450 k)
+ – – [13]
Rodents
Rat Fat (3), liver (5–6) 40,000
(HELP assay)
– – – [45]
Mouse Liver (15), heart (15), lung (16), cortex (16) 1,230,000
(RRBS)
+ – – (GO terms) [46]
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411; Fig. 2a, Additional File 2: Table S2), while in mono-
cytes aDMPs mainly lost DNA methylation (gain 83, loss 
574, Additional File 2: Table  S2). Not only the number 
of DMPs but also the rates of change with age varied 
between tissues (Fig. 2b). The differences in number per 
tissue was not explained by either the known replication 
rate of the stem cells of the tissues analyzed (r = − 0.05, 
P = 0.90; Additional file  3: Fig.  S1A) or  the number of 
individuals used in each tissue (r = −  0.47, P = 0.24; 
Additional file 3: Fig. S1B).
The majority of aDMPs are tissue‑specific
The comparison of aDMPs between tissues showed that 
the large majority of aDMPs were tissue-specific (85.2% 
for gain-aDMPs and 97.4% for loss-aDMPs). Albeit low, 
the number of aDMPs shared between multiple tissues was 
higher for gain-aDMPs than for loss-aDMPs (Fig.  2c). Of 
the gain-aDMPs, 1161 (14.8%) were identified in ≥ 2 tissues 
(Fig.  3a). Only 2 gain-aDMPs were found in all 7 tissues 
studied and both mapped to the ELOVL2 locus (Addi-
tional file  4: Table  S3), thus underscoring that the strong 
a b
Fig. 1 Age-related change in DNA methylation in ELOVL2. a DNA methylation (y axis) against age (x axis) in blood for the ELOVL2 CpG (cg16867657). 
b DNA methylation (y axis) against age (x axis) in other tissues for the ELOVL2 CpG (cg16867657)
a b c
Fig. 2 Identification of aDMPs. a Number of identified gain- and loss-aDMPs (y axis) in this study for each tissue (x axis). b Slopes of identified 
gain- and loss-aDMPs (y axis) for each tissue (x axis). c Overlap between tissues in identified gain- and loss-aDMPs. In the diagonal cells the number 
of aDMPs unique for that tissue, the upper number represents the percentage, the lower number the number of overlapping aDMPs. Blue—
gain-aDMPs; Purple—loss-aDMPs
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tissue-shared association of these CpGs with age is excep-
tional. Loci consistently identified in blood [3] were also 
found in a subset of the tissues, that is 971 aDMPs (8.0%) 
overlapped with the 7477 CpGs previously identified in 
blood including FHL2 (5 tissues) and PENK (4 tissues).
To exclude that the tissue-specificity was only due 
to the differences in size of the datasets, we performed 
three additional analyses. First, we identified aDMPs 
based on an effect size criterion only, thus eliminating 
the effect of statistical power. While CpGs in each of 
the tissues have an equal chance to become an aDMP, 
tissue-specificity was again observed in each of the tis-
sues in the 37,136 aDMPs identified (brain 4786, buccal 
27,884, liver 4225, kidney 3694, monocytes 769, SAT 
222, Th cells 721; Additional file 5: Fig. S2A). Secondly, 
we identified aDMPs in equally sized datasets (N = 96, 
based on smallest tissue datasets) with both a P value 
(Pbonf ≤ 0.05) and effect size cut-off (> 2%/10  years) 
criterion. This approach resulted in 10,249 aDMPs 
across the 7 tissues (brain 4195, buccal 4857, liver 1636, 
kidney 499, monocytes 109, SAT 23), and these aDMPs 
were equally tissue-specific between tissues (Additional 
file  5: Fig.  S2B). In these equally sized datasets, we 
observed that the aDMPs identified in one tissue were 
significant in other tissues at a less stringent P value 
cut-off (P < 0.001), suggesting that there may be a weak 
aDMP effect. However, this effect was much weaker 
as compared to the tissue the aDMP was identified in 
(Additional file 5: Fig. S2A–B, Additional file 6: Fig. S3).
Thirdly, the tissue-specificity of aDMPs was confirmed 
when we determined the age-related slope of the set of 
originally identified aDMPs in the all available 16 tissues 
(Additional file  6: Fig.  S3). Together, these analyses rein-
forced the interpretation that aDMPs are truly tissue-spe-
cific and not due to differences in statistical power to detect 




Fig. 3 Characterization of gain-aDMPs. a Frequency of aDMPs (y axis) against the number of tissues the aDMPs was identified in (x axis). b 
Enrichment of gain-aDMPs in chromatin segmentations expressed as an odds ratio, grey non-significant. c Percentage (top) and odds ratios 
(bottom) of aDMPs in CGIs, shores and non-CGIs. Blue enriched, red depleted, grey non-significant. d Percentage (top) and odds ratios (bottom) 
of aDMPs in EZH2 binding sites (ChIP-seq, any cell type, ENCODE). Blue enriched, red depleted, grey non-significant. e Frequency of CpG islands 
(y axis) against the number of tissues a CpG island was identified in (x axis). f Frequency of genes (y axis) against the number of tissues a gene 
was identified in (x axis). g Expression (y axis, RPKM) of genes near gain-aDMPs per tissue (x axis). Abbreviations: TssA active TSS, TssAFlnk flanking 
active TSS, TxFlnk transcr. at gene 5′ and 3′, Tx strong transcription, TxWk weak transcription, EnhG genic enhancers, Enh enhancers, ZNF/Rpts ZNF 
genes + repeats, Het heterochromatin, TssBiv bivalent/poised TSS, BivFlnk flanking bivalent TSS/Enh, EnhBiv bivalent enhancer, ReprPC repressed 
polycomb, ReprPCWk weak repressed polycomb, Quies quiescent/low
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changes occurring in one tissue are generally not indicative 
of age-related changes at the same CpGs in another tissue.
Identified aDMPs showed little overlap with the 353 
CpGs from Horvath’s age predictor [24] (Additional file 7: 
Fig.  S4). The maximum overlap with gain-aDMPs was 
found in brain (13 gain-aDMPs) and with loss-aDMPs in 
monocytes (6 loss-aDMPs). This is not unexpected, given 
that Horvath’s age predictor was trained using a penal-
ized regression method aimed at identifying a sparse set 
of independent predictors and the fact that it was based 
on the Illumina 27k array (and hence did for example 
not include the ELOVL2 CpGs). When Horvath’s tissue-
independent age predictor was applied to the compen-
dium of 16 tissues, the correlation between chronological 
age and predicted age was high although the precision of 
the prediction for individual samples was often limited 
(Additional file 8: Fig. S5). Only a minority of the CpGs 
that were included in Horvath’s age predictor show a 
strong association with age and the strongest tissue-spe-
cific aDMPs are missing (Additional file 9: Fig. S6). This 
illustrates the potential value of tissue-specific analyses 
to gain insight into the mechanisms linking age-related 
DNA methylation changes with tissue-specific ageing.
Gain‑aDMPs are tissue‑specific but share their functional 
annotation
Genomic annotation showed that gain-aDMPs were 
highly enriched at CpG islands (CGIs) and their shores 
as compared with non-CGI sequences in each of the 
seven tissues (OR 1.6–15.6, P < 0.0001, Fig.  3c) and 
also in whole blood (OR 17.5, P < 0.0001, Additional 
file 10: Fig. S8A). These findings are in line with previ-
ous findings [1, 16, 25]. Utilizing reference chromatin 
segmentation data (marking the biological function of 
genomic regions) of primary tissues matching the tis-
sues studied here [26], we found that gain-aDMPs pref-
erentially occur at Bivalent Enhancers (OR 2.8–8.0, 
P < 0.0001, Fig.  3b) and Repressed Polycomb (3.4–9.8, 
P < 0.0001), both characterized by the polycomb repres-
sion mark H3K27me3. The latter observation was con-
firmed by the frequent co-occurrence of gain-aDMPs 
with binding sites of polycomb (PcG) repressive com-
plex 2 (PRC2) protein EZH2. At least one-third of the 
identified gain-aDMPs overlapped with an EZH2 bind-
ing site increasing to almost two-thirds for buccal cells 
(OR 12.7, P < 0.0001, Fig.  3d). To address whether the 
enrichments for CGIs and EZH2 binding are independ-
ent or reflect the same underlying biology, we analysed 
both annotations together. Gain-aDMPs were twofold 
enriched (1.9–2.8, P < 0.0001) at genomic regions that 
were both CGIs and binding EZH2 as compared with 
regions that featured only one of the annotations (Addi-
tional file 11: Fig. S7A). This suggests that gain-aDMPs 
primarily occur at regions are both polycomb-repressed 
and CGIs. Finally, when  the same enrichment analy-
ses were performed on the whole-blood aDMPs, similar 
results were observed as compared to  the other seven 
tissues (Additional file 10: Fig. S8A–C).
CGIs and genes that gain methylation are 
also tissue‑specific
Our analysis showed that, although individual gain-
aDMPs are tissue-specific, their genomic annotation is 
shared. This was not due to different CpGs in the same 
CGI being identified as aDMPs across different tissues. 
This would go against the interpretation that gain-aDMPs 
are mainly tissue-specific. However, this was not the case. 
Of the 1,722 CGIs harbouring at least one gain-aDMP in 
at least one tissue, 70.1% were unique (Fig.  3e). The tis-
sue-specificity further extended towards genes: mapping 
gain-aDMPs to their nearest gene, resulting in 2029 genes 
that were unique for a tissue (64.8%). Only one gene was 
found in all 7 tissues, namely (as expected) the ELOVL2 
gene (Fig. 3f and Additional file 4: Table S3). The 12 genes 
that were identified in 6 out of 7 tissues included BMI1 
(involved in the DNA damage response) and LIN28B (a 
microRNA that enhances IGF-2 translation). Counting the 
number of gain-aDMPs near a gene per tissue corrobo-
rated the tissue-specificity of genes. Genes with > 5 gain-
aDMPs in one tissue had few in other tissues (Additional 
file 12: Table S4). Examples were PRRT1 in the brain (brain 
24, buccal 5, liver 7, kidney 1, monocytes 0, SAT 1, Th cell 
2) and HOXD in buccal cells (buccal 26, other tissues 0).
Next, we investigated the function of genes near gain-
aDMPs. In brain (84 processes), buccal (151 processes), 
liver (64 processes) and kidney (59 processes), multiple 
biological processes were enriched among nearest genes 
(Pbonf ≤ 0.05). Commonly and strongly enriched processes 
included embryonic morphogenesis (number of genes 
in brain 82, buccal 98, liver 69, kidney 37; Pbonf < 0.0001, 
Additional file  13: Table  S5) and regulation of transcrip-
tion (number of genes in brain 231, buccal 318, liver 209, 
kidney 134; Pbonf < 0.0001, Additional file 13: Table S5).
Finally, we investigated the expression of genes near 
gain-aDMPs using public gene expression data on tissues 
matching those studied here (GTEX data, frontal cortex, 
N = 108; oesophagus–mucosa, N = 286; liver, N = 119; 
kidney cortex, N = 32; whole blood, N = 393; age range 
20–79  years). The baseline expression of genes was low 
(in line with their repressed state and developmental 
function), and we did not observe evidence for changes in 
gene expression (Fig. 3g and Additional file 11: Fig. S7B). 
Furthermore, there was little overlap between these genes 
and those previously reported to have a changed expres-
sion with age in whole blood (brain 91, buccal 104, liver 
88, kidney 28, monocyte 1, SAT 3, Th cell 0) [27].
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Loss‑aDMPs are enriched for active regions 
including tissue‑specific enhancers
In contrast to gain-aDMPs, loss-aDMPs preferentially 
occurred in non-CGI regions (OR 1.3–9.1, P < 0.0001, 
Fig.  4a) in the seven tissues and in whole blood (Addi-
tional file 10: Fig. S8D), in line with previous reports [1, 
16, 25]. Loss-aDMPs were even more tissue-specific than 
gain-aDMPs: 4,176 loss-aDMPs (97.4%) were unique for 
one tissue and only 111 loss-aDMPs (2.6%) were found 
in ≥ 2 tissues (Fig.  4b). Again, contrasting with gain-
aDMPs, loss-aDMPs were particularly overrepresented 
at chromatin states marking active genomic regions 
(Fig. 4c). In 5 of 7 tissues, an enrichment was found for 
Enhancers including in brain (OR 6.6, P < 0.0001, Fig. 4c), 
buccal cells (OR 2.7, P < 0.0001), liver (OR 1.6, P < 0.001), 
monocytes (OR 2.9, P < 0.0001) and Th cells (OR 11.2, 
P < 0.001). For 2 tissues, an enrichment for Genic enhanc-
ers was observed including brain (OR 11.9, P < 0.0001) 
ca
db
Fig. 4 Characterization of loss-aDMPs. a Percentage and odds ratios of aDMPs in CGIs, shores and non-CGIs. Blue enriched, red depleted, grey 
non-significant. b Number of tissues an aDMPs was identified in. c Enrichment of gain-aDMPs in chromatin segmentations expressed as an odds 
ratio, grey non-significant enrichment. d Frequency of genes (y axis) against the number of tissues genes were identified in (x axis). e Expression of 
genes (y axis, RPKM) near loss-aDMPs per tissue (x axis). Abbreviations: TssA active TSS, TssAFlnk flanking active TSS, TxFlnk transcr. at gene 5′ and 3′, 
Tx strong transcription, TxWk weak transcription, EnhG genic enhancers, Enh enhancers, ZNF/Rpts ZNF genes + repeats, Het heterochromatin, TssBiv 
bivalent/poised TSS, BivFlnk flanking bivalent TSS/Enh, EnhBiv bivalent enhancer, ReprPC repressed polycomb, ReprPCWk weak repressed polycomb, 
Quies quiescent/low
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and buccal (OR 3.6, P < 0.0001). Moreover, loss-aDMPs 
were overrepresented at actively transcribed regions, 
including Transcribed at 3′and 5′ in brain (OR 14.5, 
P < 0.0001), buccal (OR 3.0, P < 0.0001) and monocytes 
(OR 4.6, P < 0.01). Again, these observations were compa-
rable with enrichments for aDMPs in whole blood (Addi-
tional file 10: Fig. S8E).
Mapping loss-aDMPs to their nearest gene showed 
that the majority of genes uniquely occurred in a single 
tissue (2035 genes, 83.6%, Fig.  4d). The relatively few 
genes found in multiple tissues included CD46 observed 
in 6 out of 7 tissues and KCNQ1, FAM92B, PLEC, GSE1, 
BAIAP2, PRDM16 and ACTG1 found in 4 tissues (Addi-
tional file  14: Table  S6). Many of these genes have a 
‘housekeeping’ function. For example, PLEC, BAIAP2, 
ACTG1 play a role in the maintenance of the cytoskel-
eton. The tissue-specificity of loss-aDMP genes was cor-
roborated when counting the number of loss-aDMPs per 
gene. For example, 24 loss-aDMPs were identified near 
DIP2C in the brain, against low numbers in other tis-
sues (buccal 1, liver 3, kidney 0, monocytes 0, SAT 0, Th 
cell 0). In buccal, 18 CpGs lost DNA methylation near 
SLC7A5, while no loss-aDMPs were found near this gene 
in other tissues (Additional file 15: Table S7).
Only loss-aDMP genes in brain showed enrichment 
for specific biological processes, including regulation of 
Small GTPase-mediated signal transduction (43 genes, 
Pbonf < 0.0001) and Regulation of cell motion (33 genes, 
Pbonf < 0.05, Additional file 16: Table S8). For the other tis-
sues, similar processes related to intracellular signalling 
and cell motility were overrepresented (P < 0.05).
Finally, we investigated the expression of genes near 
loss-aDMPs. Their expression levels were moderate 
(Fig.  4e), but no evidence was observed for age-related 
changes (Additional file 11: Fig. S7C). Also, only a limited 
overlap was found with previously identified age-related 
differentially expressed genes in whole blood (brain 114; 
buccal 77, liver 23, kidney 3, monocyte 36, SAT 0, Th cell 
1) [27].
Discussion
Using genome-wide DNA methylation data on a large 
number of individuals and 16 tissues, we report a cata-
logue of 7850 robust aDMPs, 92% of which had not been 
previously reported in studies of whole blood, and show 
that age-related changes in DNA methylation are highly 
tissue-specific. The exceptions to this are well-known 
CpGs in the ELOVL2 promoter that display an exception-
ally consistent increase in DNA methylation with age in 
all tissues studied here [15]. Age-related gain of DNA 
methylation (gain-aDMPs) accumulated at CpG islands 
and their flanking regions that were bound by the repres-
sive PRC2 component EZH2. In contrast, loss-aDMPs 
were enriched for active regions, including enhanc-
ers. Underscoring the tissue-specificity of aDMPs, we 
observed that the large majority of both CGIs and genes 
with at least one aDMP were observed in a single tissue 
only.
Our results raise the question of what mechanism 
drives the age-related DNA methylation changes. Despite 
the tissue-specificity of individual aDMPs, in all tis-
sues it was the same type of functional genomic region 
that accumulated aDMPs. We were able to exclude dif-
ferences in the number of stem cell divisions between 
tissues as a potential explanation. In line with our find-
ings for gain-aDMPs, age-related changes at regions 
marked by polycomb have been found in many studies 
investigating blood [7, 9, 10, 28] and have been found in 
other species [17, 29]. A previously proposed explana-
tion for the gain of DNA methylation in CpG islands is 
by loss of binding—or erosion—of the polycomb repres-
sive complex 2 protein from the DNA (PRC2) [30]. CGI 
promoters of developmental genes that are expressed at 
low levels are kept in a repressive state primarily by the 
repressive complex PRC2 of which EHZ2 is a key com-
ponent. Age-related loss of repression would allow DNA 
methyltransferases (DNMTs) to de novo methylate CGIs 
[30]. This explanation, however, requires a region and tis-
sue-specific mechanism that renders a subset of regions 
more susceptible to age-related erosion of PRC2, which 
is currently unknown. While the genomic annotations 
that show age-related gain across tissues were the same, 
the actual loci were tissue-specific, suggesting common 
underlying mechanisms that link to tissue-specific age-
related changes.
In contrast to gain-aDMPs, loss-aDMPs overlapped 
with active genomic regions, such as enhancers, corrob-
orating earlier studies in whole blood and mesenchymal 
stem cells [10, 13, 27]. Despite their tissue-specificity, 
genes near loss-aDMPs were not enriched for features 
conveying a role in tissue-specific processes, but instead 
with generic processes such as intracellular signalling 
cascade and cell motility pathways in line with findings in 
whole blood [3].
Remarkably, we did not find evidence for age-related 
changes in expression of genes near aDMPs. This con-
firms previous studies that aDMPs, including ELOVL2, 
have limited functional consequences [3, 9]. An explana-
tion for the consistent increase in DMPs near ELOVL2 
and other age-related DNA methylation changes could be 
due to underlying mitotic changes, although this has not 
been observed in previous studies suggesting other mech-
anisms driving age-related DNA methylation changes [31, 
32]. In contrast to aDMPs, CpGs accumulating variability 
in the population with age (aVMPs) are commonly asso-
ciated with gene expression changes and may be more 
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informative for biological age [23]. Nonetheless, age-
related epigenetic changes show resemblance with the 
changes seen in cancer and cellular senescence [28]. For 
example, the number of passages in vitro can be tracked 
based on the changes that occur at the DNA methylation 
level [33]. Moreover, cellular senescence is associated with 
hypermethylation of CGIs and flanking regions, while 
hypomethylation occurs at non-CGI features [34, 35]. 
Cancer is also characterized by hypermethylation of CpG 
islands and global hypomethylation [36, 37]. Here, we 
observed a higher fraction of CpGs to gain DNA meth-
ylation with time as compared with loss. However, this is 
likely due to the bias of the 450 k array towards CpG-rich 
regions. After all, in a previous study comparing whole-
genome bisulphite sequencing DNA methylation data of 
newborn versus a centenarian observed a much higher 
fraction of CpGs to be hypomethylated in the centenarian 
than hypermethylated [25].
A limitation of our study is that not all datasets were 
equally sized. Larger datasets will have higher statistical 
power to detect aDMPs  with smaller effect sizes. How-
ever, we showed that there was no relationship between 
sample size and the tissue-specific character of aDMPs as 
this was preserved if aDMPs were identified only based 
on effect size, in equally sized datasets, or in 16 instead 
of 7 tissues. Also, one would expect at least to find an 
overlap between the strongest associated aDMPs, but 
this was not the case. Inspection of effect sizes showed 
that CpGs detected as aDMPs in one tissue commonly 
showed little or no evidence for an age-related change in 
DNA methylation in other tissues. However, larger stud-
ies are required to definitely exclude smaller effects in 
other tissues.
Another limitation of our study is that the age ranges 
across the different tissues were different, which will have 
influenced the number of aDMPs detected. Age-related 
DNA methylation changes are known to accumulate 
faster during adolescence than in adulthood [38, 39]. This 
may have contributed the identification of the largest 
number of aDMPs in the smallest dataset, namely buc-
cal (n = 96; age range 1–28). Finally, our results may be 
influenced by measured and unmeasured confounding, 
such as smoking, BMI, ethnicity and shifts in cell hetero-
geneity [7]. Some of the changes identified here may also 
be the result of a shift in cellular composition of a tissue 
with age, although we adjusted for cellular heterogene-
ity in brain (neuronal and non-neuronal), monocytes, Th 
cells (residual impurities) and blood.
Conclusion
Together, our results show that while the individual 
CpGs that exhibit age-related differential methylation 
are highly tissue-specific, the type of functional genomic 
elements involved are highly consistent across tissues. 
Gain of methylation occurs at CGIs repressed by PRC2, 
while loss of methylation accumulates at regions with 
active histone marks. Our findings indicate that the pre-
cision of age predictors based on DNA methylation will 
depend on whether the tissue of interest was among the 
tissues on which set the predictor was trained on. Our 
catalogue of tissue-specific aDMPs may guide the devel-
opment of more precise predictors of chronological and 
perhaps eventually provide insight into the tissue-specific 
differences in the mechanisms underlying ageing.
Methods
Datasets
Datasets used in this study are summarized in Additional 
file 1: Table S1 and were obtained from the Gene Expres-
sion Omnibus or ArrayExpress. For each of the datasets, 
normalized data or raw IDAT files were obtained. IDAT 
files of DLPFC samples (age range 0–97  years) were 
downloaded (GEO accession number: GSE74193). Ini-
tial QC was performed using the R package MethylAid 
[40]. Raw data underwent quality control using a cus-
tom pipeline (for more details see https ://git.lumc.nl/
molep i/Leide n450K ). Briefly, data were normalized using 
functional normalization (minfi), and probes were set to 
missing if ambiguously mapped, had a high detection P 
value (> 0.01), low bead count (< 3 beads) or low success 
rate (missing in > 95% of the samples). Normalized data 
of buccal (GEO accession number: GSE50759, normali-
zation: SWAN method on M values) consisted of 1202 
individuals with an age range of 1–28  years. Liver data 
consisted of 147 individuals with age range between 15 
and 86, normalized data of 56 individuals (GEO accession 
number: GSE48325, normalization using control probes), 
normalized data of 32 individuals (GEO accession num-
ber: GSE61258, normalization using control probes), 
IDAT files (Level 1) of 30 samples from TCGA and IDAT 
files of 29 samples were kindly provided by the authors 
(GSE60753). Given that the liver dataset consisted of 
dataset from different origins, we carefully inspected for 
batch effects influencing the age-related changes. The 
first principal components associated with study, sex 
and age. To limit the effect of data origin, study ID was 
added to the model. IDAT files (Level 1) of kidney con-
sisted of 171 individuals with an age range between 15 
and 86 and were obtained from TCGA. Normalized data 
of monocytes (GEO accession number: GSE56046, nor-
malization: quantile normalization per colour signal and 
probe type) consisted of 1,202 individuals with an age 
range of 44–83 years. Normalized data of Th cells (GEO 
accession number: GSE56047, normalization: quantile 
normalization) consisted of 214 individuals with an age 
range of 45–79 years). Normalized data of subcutaneous 
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fat (Array Expression accession number: E-MTAB-1866, 
quantile normalized per probe type) consisted of 648 
individuals with an age range of 39–85  years. Normal-
ized data of multiple brain regions consisted between 
25 and 41 individuals with an age range between 15 and 
114 years (GEO accession number: GSE64509, normali-
zation using control probes). Raw IDAT files of epider-
mis and dermis consisted 38 and 40 individuals between 
20 and 90  years (GEO accession number: GSE52980). 
Normalized data of skeletal muscle consisted of 48 indi-
viduals with an age range between 18 and 89 years (GEO 
accession number: GSE50498, normalization: quantile 
normalization on M values). Raw IDAT files of thyroid 
were kindly provided by the authors and consisted of 
28 individuals between 23 and 81 years (GEO accession 
number: GSE53051).
Blood dataset
DNA methylation blood data consisted of 3,295 from 
six Dutch biobanks, previously described [23]. Briefly, 
data were normalized using functional normalization 
(R package minfi) using five principal components [41], 
poorly performing and ambiguously mapped CpGs were 
removed as well as CpGs on the sex chromosomes. Com-
bat was used to remove residual batch effects [42].
Gene expression
Gene counts were obtained from GTEX for frontal cor-
tex (for brain-aDMPs measured in DLPFC), oesophagus 
mucosa (for buccal-aDMPs), liver, kidney cortex and 
whole blood (for Th cell-aDMPs and monocyte-aDMPs). 
The package cqn was used to normalize for GC content 
and gene length. Normalized data was used to calculate 
the average RPKM per tissue and gene.
Statistical analysis
aDMPs were identified using linear regression between 
DNA methylation and age, with adjustment for covari-
ates (sex, gender (all but SAT, females only), dataset 
(liver), tissue cell composition (DLPFC, monocytes, 
Th cells, whole blood). For monocytes and Th cells, 
residual cell impurities were included in the model. For 
whole blood, blood cell fractions were included as pre-
viously described [23]. Age was included in the model 
as a non-transformed numeric variable. aDMPs were 
used in subsequent analyses if the slope was higher 
than 2% gain or loss per 10 years and if the Bonferroni 
adjusted P value reached significance (Pbonf ≤ 0.05). 
To investigate the relation between power and the 
observed tissue-specific character of aDMPs, we identi-
fied aDMPs solely based on the effect size (age-related 
slope > 2%/10  year, no P value cut-off ). Secondly, a 
random set of individuals was drawn from each of the 
tissue datasets with the size equal to the smallest data-
set (N = 96). aDMPs were identified on these equally 
sized datasets with both an effect size (> 2%/10  years) 
and P value criterion (Pbonf ≤ 0.05).
Annotations
CpGs were mapped to CpG islands (UCSC), shores 
(2-kb regions flanking regions) and non-CGI described 
previously [43]. Chromatin state segmentations were 
obtained from the Epigenomics Roadmap. For each tis-
sue studied, the same tissue or the closest analogue was 
used from the Roadmap data. For the DLPFC, E073/
DLPFC was used; buccal, E058/keratinocyte foreskin; 
liver, E066/liver; kidney, E086/foetal kidney; SAT, E063/
Adipose nuclei; monocytes, E029/Monocytes; Th cells, 
E043/Th cells. For blood, functionality of a certain 
regions was based on the most frequent occurring fea-
ture in primary blood cell subtypes. ChIP-seq data of 
EZH2 was obtained for all cell types from the ENCODE 
project. Enrichments were expressed as odds ratio, and 
P value were calculated using a Chi-squared test. GO 
enrichment was performed using the default settings 
of DAVID using nearest genes (UCSC, 3′ or 5′ end of 
genes closest to the CpG) of aDMPs [44].
Additional files
Additional file 1: Table S1. Number of individuals used per tissue in this 
study.
Additional file 2: Table S2. Identified aDMPs per tissue.
Additional file 3: Figure S1. A Number of aDMPs (y axis) in our study 
against the previously reported number of stem cell divisions per year (x 
axis) [47]. B Number of aDMPs (y axis) against the sample size (x axis).
Additional file 4: Table S3. Number of tissues a gene near gain-aDMPs 
was found.
Additional file 5: Figure S2. A Heatmap of slopes of aDMPs identified 
with only an effect size criterion. B Heatmap of slopes of aDMPs identified 
in equally sized datasets comprising randomly selected 96 individuals. 
Scale represents the change in DNA methylation in %/10 years. C Number 
of significant (P < 0.001) aDMPs in the other tissues in the equally-sized 
datasets.
Additional file 6: Figure S3. Heatmap of slopes of age-related DNA 
methylation in 16 tissues. Scale represents the change in DNA methyla-
tion in %/10 years.
Additional file 7: Figure S4. Overlap between gain- and loss-aDMPs and 
the CpGs in Horvath’s clock.
Additional file 8: Figure S5. Chronological age against the Horvath’s 
predicted age for each of the 16 tissues.
Additional file 9: Figure S6. Volcano plots of all CpGs per tissue, age-
related change (x axis) versus P value (y axis). CpGs from Horvath’s age 
predictor are marked in blue.
Additional file 10: Figure S8. A Percentage (top) and odds ratios 
(bottom) of gain-aDMPs in CGIs, shores and non-CGIs. Blue enriched, 
red depleted, grey non-significant. B Percentage (top) and odds ratios 
(bottom) of aDMPs in EZH2 binding sites in the seven tissues plus whole 
blood (ChIP-seq, any cell type, ENCODE). Blue enriched, red depleted, grey 
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